Verastem Inc

Financials

Total assets 154.35 M108.66 M95.05 M149.72 M101.54 M Total liabilities 39.08 M21.1 M47.66 M71.19 M130.43 M Total equity 115.27 M87.56 M47.39 M57.37 M28.89 M Total liabilities & shareholders' equities 154.35 M108.66 M95.05 M149.72 M101.54 M Total debt ————— Net debt —————

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

VSTM

Financials

Verastem Inc

Haberler

What Makes Verastem (VSTM) a New Buy Stock

Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results

B.Riley, Verastem hissesi için Al derecelendirmesini yineliyor, 16 dolar hedefini koruyor

B.Riley reiterates Buy rating on Verastem stock, maintains $16 target

Verastem, kanser tedavisi için 4. çeyrekte 17,5 milyon dolar gelir bildirdi

Verastem reports $17.5 million in Q4 revenue for cancer treatment

Verastem stock rating initiated at Buy by H.C. Wainwright with $18 target

Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)

Revolution Medicines stock surges over 20% on potential AbbVie acquisition

Revolution Medicines hisseleri olası AbbVie satın alımıyla %20’den fazla yükseldi

What's Going On With Verastem Stock Friday? - Verastem (NASDAQ:VSTM)

Mizuho, Verastem için Outperform notunu yineledi